Biosante Pharmaceuticals
Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: placebo gel
- First Posted Date
- 2010-11-07
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- BioSante Pharmaceuticals
- Target Recruit Count
- 626
- Registration Number
- NCT01235754
- Locations
- 🇺🇸
BioSante Site #095, Hoover, Alabama, United States
🇺🇸BioSante Site #014, Huntsville, Alabama, United States
🇺🇸BioSante Site #146, Mobile, Alabama, United States
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: placebo gel
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- BioSante Pharmaceuticals
- Target Recruit Count
- 575
- Registration Number
- NCT00657501
- Locations
- 🇺🇸
BioSante Site #146, Mobile, Alabama, United States
🇺🇸BioSante Site #171, Chandler, Arizona, United States
🇺🇸BioSante Site #145, Glendale, Arizona, United States
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: placebo gel
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- BioSante Pharmaceuticals
- Target Recruit Count
- 3656
- Registration Number
- NCT00612742
- Locations
- 🇺🇸
BioSante Site #215, Birmingham, Alabama, United States
🇺🇸BioSante Site 185, Birmingham, Alabama, United States
🇺🇸BioSante Site 095, Hoover, Alabama, United States
Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Drug: placebo gel
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2013-01-10
- Lead Sponsor
- BioSante Pharmaceuticals
- Target Recruit Count
- 597
- Registration Number
- NCT00613002
- Locations
- 🇺🇸
BioSante Site #215, Birmingham, Alabama, United States
🇺🇸BioSante Site #095, Hoover, Alabama, United States
🇺🇸BioSante Site #014, Huntsville, Alabama, United States
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
- Conditions
- Hot Flashes
- First Posted Date
- 2006-10-24
- Last Posted Date
- 2006-10-24
- Lead Sponsor
- BioSante Pharmaceuticals
- Target Recruit Count
- 431
- Registration Number
- NCT00391417